Is HLN.L (Haleon plc) Halal or Haram?

Based on our AAOIFI-standard shariah screening, HLN.L is Halal and considered permissible for Muslim investors. It passed all 4 of 4 compliance screens including business activity review, debt-to-market-cap ratio (23.83% vs ≤33% threshold), interest income ratio (0.71% vs ≤5% threshold), and cash & securities ratio (3.66% vs ≤33% threshold).

Haleon plc is a global leader dedicated entirely to consumer healthcare, formed from the de-merger of GSK's consumer division. It owns household names you likely use daily, such as Sensodyne and Parodontax for oral health, Panadol and Advil for pain relief, and Centrum for nutritional support. Unlike pharmaceutical giants that focus on prescription drugs, Haleon specializes in over-the-counter products that consumers purchase directly from pharmacies and supermarkets. For Muslim investors, Haleon is classified as Halal, having passed all four key AAOIFI screening tests. The company's business model is fundamentally permissible, focusing on health and wellness products without exposure to haram sectors like alcohol production or conventional insurance. This 'clean' operational base makes it a straightforward choice for those building an ethical, faith-based portfolio. Financially, the company demonstrates discipline that aligns well with Islamic finance principles. Its debt-to-market cap ratio is 23.8%, which is comfortably under the 3 3% threshold, indicating it is not overly leveraged with interest-bearing loans. Furthermore, its income from interest-bearing deposits is extremely low at 0.71%, meaning almost all its revenue comes from genuine trade rather than impermissible financial gains. Investors should continue to monitor the debt levels, as large acquisitions in the consumer health space can sometimes lead to spikes in borrowing. However , Haleon currently presents a stable profile with no major controversies regarding shariah compliance. Regular quarterly screening is recommended to ensure these ratios remain within the acceptable AAOIFI limits. Haleon plc operates in the Healthcare sector under the Drug Manufacturers - Specialty & Generic industry and is headquartered in Weybridge, GB. The company is led by CEO Brian James McNamara and employs approximately 24,561 people.

HLN.L was screened using AAOIFI-based shariah compliance criteria. Four tests are applied: (1) Business Activity — the company's core business must not derive primary income from haram (prohibited) activities such as alcohol, gambling, tobacco, or interest-based finance. (2) Debt-to-Market-Cap — total debt must not exceed 33% of market capitalization. (3) Interest Income — interest income must not exceed 5% of total revenue. (4) Cash & Securities — cash and interest-bearing securities must not exceed 33% of market cap. HLN.L passed 4 of these 4 screens.

Although HLN.L passes all shariah screens, it does earn $78.0M in interest income (0.71% of revenue). Many scholars recommend purifying this portion by donating the equivalent percentage of any dividends received to charity. For example, if you receive $100 in dividends, you would donate approximately $0.71 to purify the income.

HLN.L was last screened on 2026-03-01. Shariah compliance status can change as companies report new financial data, acquire new businesses, or shift revenue streams. We recommend checking back periodically for the most up-to-date screening results.